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Using a combination of cyanogen bromide cleavage and endoproteinase digestion we have shown that the putative epitope for the mon~lonal 
antibody FACZ lies in the region 3mPrcrlg1Ser on the apoprotein of CPa-1. This region lies entirely within the large extrinsic loop of this protein. 
We have shown previously that the epitope of FAC2 becomes exposed in oxygen-evolving membranes upon treatment with alkaline Tris which 
releases all four of the manganese associated with the oxygen-evolving site of photosystem II. The epitope is not exposed, however, after CaCI, 
treatment and exposure to low concentrations of chloride, conditions which lead to the release of two of the four manganeses associated with 
the oxygen-evolving site [(1987) Arch. B&hem. Biophys. 256,295-3011. These rest&s suggest hat, upon release of the c~o~de-in~nsitive manga- 
nese from photosystem II membranes, a conformational change occurs which leads to the exposure of 360Pro-sg’Ser on CPa-1 to the monoclonal 
antibody FACZ. 
Photosystem II; Protein, CPa-1; Monoclonal antibody; Epitope mapping 
1. INTRODUCTION 
At least seven proteins appear to be required for 
photosynthetic oxygen evolution within the photo- 
system II (PS II) membrane protein complex [ 11. These 
include the 47 kDa protein CPa-1 (CP47), the 45 kDa 
protein CPa-2 (CP43), the 34 kDa Dl protein, the 32 
kDa D2 protein, the extrinsic 33 kDa manganese- 
stabilizing protein, and the 9 and 4.5 kDa subunits of 
cytochrome b-559. Additionally, several ow molecular 
mass polypeptides have recently been identified which 
appear to be associated with PS II [2]. At least one of 
these, the 4.1 kDa product of the p&I gene, appears to 
be associated with the PS II reaction center [3]. The 
oxygen-evolving complex also contains a number of in- 
organic cofactors which are absolutely necessary for 
water oxidation. These cofactors include bound 
manganese, calcium and chloride [4-61. In vivo, the 
proteins Dl, D2 and cytochrome b-559 may form the 
reaction center of PS II and bear as prosthetic groups 
the primary and secondary electron acceptors and 
donors of the photosystem (YZ, P680, pheophytin, QA, 
and, probably, QB). Dl-DZcytochrome b-559 com- 
plexes have been isolated from both higher plants 17-91 
and recently from cyanobacteria [ IO]. These complexes, 
however, do not contain QA and cannot maintain a 
stable charge separation. Additionally, this complex 
does not contain bound manganese and is non- 
functional with respect to oxygen evolution. The pro- 
teins which bind the inorganic cofactors involved in ox- 
ygen evolution and the extrinsic 33 kDa protein have 
not been unambiguously identified. Interestingly, all PS 
II submembrane complexes which have been isolated to 
date which have the ability to evolve oxygen contain the 
two chlorophyll-proteins CPa-1 and CPa-2. 
In a previous communication [l l] we described the 
properties of the monoclonal antibody FAC2, which 
recognized the chlorophyll-protein CPa-1. Interesting- 
ly, alkaline Tris-treatment, which removes the strongly 
bound pool of manganese associated with the oxygen- 
evolving site, increases the exposure of the antigenic 
determinant of FAC2. In this communication we have 
localized the putative antigenic determinant of the 
monoclonal antibody FAC2 to a 32 amino acid residue 
region located in the large extrinsic loop region of 
CPa-1. These findings suggest hat this region of CPa-1 
may interact structurally with the PS II component(s) 
responsible for manganese ligation. 
2. MATERIALS AND METHODS 
Correspondence address: LX. Frankel, Department of Botany, 
Louisiana State University, Baton Rouge, LA 70803, USA 
A hybridoma cell line which secretes the monoclonal antibody 
FAC2 was isolated after immuni~tion of BalbK mice with purified 
PS II core I121 as previously described [13,14]. The 49 kDa apoprotein 
of CPa-1 was isolated by preparative lectrophoresis of CaCla-washed 
PS II oxygen-evolving membranes isolated by the procedure of 
Ghanotakis and Babcock 1141 using the buffer system of Delepelaire 
and Chua 1151. 2.0 mg Chl of the CaCla-washed membranes were 
separated on a 15% polyacrylamide gel with the dimensions 1.5 mm 
X 12 cm x 14 cm. Electrophoresis conditions were 1 .O W for 20 h at 
4°C. The preparative gels were stained with acid-free Coomassie blue 
(0.1% Coomassie brilliant blue in 25% MeOH) for 1 h and destained 
with 25% MeGH. Cyanogen bromide (CNBr) treatment of the CPa-1 
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apoprotein within gel fragments was carried out by the procedure of apoprotein of CPa-1. With Coomassie blue staining, 
Nikodem and Fresco [15] at a CNBr concentration of 55 mg/ml for 
24 h. After CNBr cleavage, the peptide fragments were separated in 
nine major CNBr fragments ranging in apparent 
the electrophoretic system of Shagger and Von Jagow [17) which molecular mass between 15.7 and 2 kDa are observed 
clearly resolves peptides of low apparent molecular mass (I-30 kDa). (fig.1). Several other minor fragments are also visible 
The 15.7 kDa CNBr fragment which bears the epitope of FAC2 (see and are probably the result of incomplete cleavage. 
below) was excised from these gels after staining with acid-free 
Coomassie blue as previously described, and electroeluted in a buffer 
Upon probing with the monoclonal antibody FAC2, a 
containing 0.025 M Tris, 0.19 M glycine, pH 8.3, and 0.1% lithium 
single major CNBr fragment is observed with an ap- 
dodecyl sulfate overnight at room temperature at 1 W. After elec- parent molecular mass of 15.7 kDa (fig.1). The N- 
troelution, the 15.7 kDa peptide was transferred to a buffer contain- terminal amino acid sequence of this peptide is PTFFE. 
ing 100 mM Tris-HCI, pH 6.8, and treated with 0.63 mg/ml carbox- 
ypeptidase Y (Sigma Chemical Co., catalog no. C-3888, lot no. 
Examination of the derived amino acid sequence of the 
37F-8135) in the presence of freshly prepared phenylmethylsulfonyl 
spinach p&B gene which encodes CPa-1 [26] indicates 
fluoride (PMSF) at a concentration of 5 mM for various times at that the predicted CNBr fragment K (3~Pro-5a*Val) 
37°C. The resulting peptides were then electrophoresed in the low contains this N-terminal sequence (see table 1). The 
molecular mass resolving gel system noted above. After elec- predicted mass of CNBr peptide K is 16.7 kDa which 
trophoresis, peptide fragments were transferred to Immobilon PVDF 
membrane (Millipore Co.) by electroblotting and either stained with 
corresponds well with the observed apparent molecular 
acid-free Coomassie blue (destained with 50% MeOH), or blocked 
mass. ~ydropathy plot analysis [18] indicated that 
with 5% non-fat dry milk in TS buffer (150 mM NaCl, 10 mM Tris- CNBr peptide K (149 amino acid residues) contains 
HCl, pH 7.2). After blocking, the blots were then probed with FAC2 about L/z of the predicted large extrinsic loop of CPa-1 
ascites fluid at a 1:2000 dilution in 1 To BSA in TS buffer overnight at as well as the sixth transmembrane helix and the 
room temperature. The blots were then developed by incubation with 
goat anti-mouse IgG + IgM-alkaline phosphatase conjugate (1:2000 
hydrophilic C-terminus of CPa-1 (see fig.3). 
dilution in 1% BSA in TS) and incubation with BCIP and NBT. For In an effort to define further the location of the an- 
sequencing, Coomassie blue stained bands were excised from the Im- tigenic determinant of FAC2, the 15.7 kDa CNBr- 
mobilon and subjected to automated Edman degradation with either peptide was isolated by preparative eIectrophoresis, 
an Applied Biosystems 470A or Porton PI 2090 sequencer. electroeluted, and treated with a variety of proteolytic 
enzymes (data not shown). The majority of these 
3. RESULTS AND DISCUSSION treatments either destroyed the antigenic determinant 
Fig.1 shows the results of CNBr cleavage of the 
of FAC2 or produced large fragments of the 15.7 kDa 
peptide which were of little use for further defining the 
location of the antigenic determinant. Experiments with 
COOlTlClSSle carboxypeptidase Y purchased from Sigma Chemical 
blue FAC 2 
‘A B’ ‘A 5’ 
Co. (catalog no. C-3888, lot no. 37F-8135), however, 
proved to be very interesting. Preliminary experiments 
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Fig. 1, Western blot analysis of cyanogen bromide cleavage of CPa-1. 
After cyanogen bromide treatment, electrophoresis and transfer to 
Immobilon, lanes A (- CNBr) and B (+ CNBr) were either stained 
with Coomassie blue or blocked and then probed with the monoclonal 
antibody FACZ. A single major band at 15.7 kDa which binds the 
monoclonal antibody is observed after cyanogen bromide treatment. 
Fig.2. Western blot analysis of a timecourse of treatment of the 
isolated 15.7 kDa cyanogen bromide fragment with Sigma carboxy- 
peptidase Y (catalog no. C-3888, lot no. 37F-8135) in the presence of 
5 mM PMSF. After enzyme treatment and electrophoresis, the pro- 
teins were transferred to Immobilon, blocked, and probed with the 
monoclonal antibody FACZ. Lanes: A, 0 min incubation, no enzyme; 
B, 0 min + enzyme; C, 15 min + enzyme; D, 30 min + enzyme; E, 60 
min + enzyme. One major fragment was observed which bound the 
monoclonal antibody FACZ. This is located at about 2 kDa. 
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Predicted cyanogen bromide fragments from the spinach p&B gene product [26] (CPa-1) and 
sequences of isolated peptides bearing the epitope of the monoclonal antibody FAC2 
Table 1 
Predicted cyanogen bromide fragments 
Peptide 
A 
B 
C 
D 
E 
F 
G 
H 
I 
J 
K 
N-terminal sequence 
2GLPWYRHTV.....25M 
26HTALVAGWA.. . .“M 
‘*ALYELAVFD.. .“M 
s6WRQG60M 
6’FV1PF66M 
67TRLGITNSW.. . .lo2M 
io3FSGLCFLAA .23’M . . . . 
232GNIETVLSS... ..256M 
257WYGSATTPI.....330M 
33’DNGDGIAVG.....359M 
3aPTFFETFPV.. . . .“‘V 
Molecular mass (kDa) 
2.1 
1.2 
2.0 
0.7 
0.7 
3.8 
14.1 
2.5 
8.5 
3.3 
16.7 
Sequences of isolated peptides which bear the epitope of FAC2 
Peptide N-terminal sequence Apparent molecular mass (kDa) 
15.7 kDa CNBr fragment PTFFE 15.7 
2kDa endoproteinase 
fragment of 15.7 kDa peptide PTFFETFPVVLIDGDGIVRADV 2.0 
demonstrated that this carboxypeptidase Y preparation molecular mass of 2.0 kDa was observed which reacted 
was contaminated with an unidentified, PMSF- with the monoclonal antibody FAC2. Upon extended 
insensitive endoproteinase activity. Carboxypeptidase incubation (data not shown) the 2.0 kDa fragment was 
Y obtained from Calbiochemical Co. did not exhibit further digested and could not be detected by either im- 
this endoproteolytic activity. The results obtained from munoprobing or Coomassie blue staining. N-terminal 
treating the 15.7 kDa CNBr fragment with Sigma car- sequencing of the 2.0 kDa fragment yields the following 
boxypeptidase Y in the presence of 5 mM PMSF are sequence: PTFFETFPVVLIDGDGIVRADV, which 
shown in fig.2. A major fragment with an apparent corresponds to the N-terminal 22 amino acid residues of 
Fig.3. Hydropathy plot of the predicted amino acid sequence [26] of thepsbB gene product, CPa-1. Rao-Argos membrane-spanning parameters 
[18] were used and smoothed twice over a span of seven amino acid residues. Putative membrane-spanning alpha helixes are shown by roman 
numerals I-VI. Hydrophilic regions which are predicted to be located on the lumenal side of the membrane by Von Heijne and Gavel analysis [25] 
are shaded. The location of the large extrinsic loop region of CPa-1 is indicated. The location of the putative epitope of the monoclonal antibody 
FAC2 is labeled and also indicated by the bold line. Both the N- and C-termini of this protein are predicted to be located on the stromal side of 
the membrane. 
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CNBr-peptide K. Because short peptides often migrate 
anomalously in SDS-PAGE and because of the dif- 
ficulties in sequencing short peptides (primarily loss of 
sample Immobilon), we conservatively suggest hat the 
epitope for FAC2 lies within the N-terminal 32 amino 
acid residues (360Pro-391Ser) of the N-terminus of the 
CNBr peptide K and is located entirely in the large ex- 
trinsic loop region of CPa-1. These results have been 
summarized in table 1. 
Our results indicate that the putative epitope for the 
monoclonal antibody FAC2 lies within the large extrin- 
sic loop of the apoprotein of CPa-1. In an earlier study, 
we had shown that this antibody not only recognizes 
CPa-1 on ‘Western blots’ but also on PS II membranes 
which had been attached to ELISA plates [I 11. We 
observed that the accessibility of FAC2 to its antigenic 
determinant was greatly increased by alkaline Tris- 
treatment of PS II membranes. This treatment removes 
the extrinsic 33 kDa manganese-stabilizing protein as 
well as the four strongly bound manganeses associated 
with the oxygen-evolving site of PS II. The antigenic 
determinant was not exposed after CaClz treatment 
followed by incubation of the PS II membranes in low 
chloride buffer. This treatment removes the manga- 
nese-stabilizing protein and leads to a loss of two of the 
four manganeses associated with the oxygen-evolving 
site. We concluded that removal of the two chloride- 
insensitive manganeses led to a conformational change 
in components associated with PS II which influenced 
the exposure of the antigenic determinant of FAC2 on 
CPa-1. This conformational change leads to the ex- 
posure of the region 360Pro-391Ser on CPa-1. It is temp- 
ting to speculate on the nature of this conformational 
change. Several lines of indirect evidence appear to in- 
dicate that the manganese associated with the oxygen- 
evolving site is associated with the Dl and/or D2 pro- 
teins of the PS II reaction center [19,20]. Additionally, 
results from our laboratory and others have strongly 
suggested that CPa-1 is closely associated with the ex- 
trinsic manganese-stabilizing protein. The manganese- 
stabilizing protein shields CPa-1 from tryptic attack 
[ 111, the presence of the manganese-stabilizing protein 
prevents labeling of lysyl residues on CPa-1 by NHS- 
biotin [21], and Cpa-1 can be crosslinked to the 
manganese-stabilizing protein by a number of protein 
crosslinkers ([21,22]; Edith Camm, personal com- 
munication). After crosslinking of CPa-1 with the 
manganese-stabilizing protein, the strongly bound 
manganese is not released by alkaline pH treatment 
[23]. We have suggested that CPa-1, in addition to its 
role as an interior chlorophyll-a antenna protein for 
PS II, may provide a binding site for the manganese- 
stabilizing protein [21]. Additional binding sites may be 
located on the Dl-D2-cytochrome b-559 complex [24]. 
With these data in mind, it is easy to imagine a model 
in which release of the strongly bound manganese from 
the PS II core leads to structural changes within the 
282 
D 1 -D2-cytochrome b-599 complex. These changes 
could lead to an increased exposure of 360Pro-39’Ser on 
CPa-1 to the external environment. It should be noted 
that no unequivocal evidence is available demonstrating 
the ligation of manganese directly to the Dl-D2-cyto- 
chrome b-599 complex. If the manganese is associated 
with other, as yet unidentified PS II components, then 
conformational changes in these other proteins upon 
manganese removal would lead to an exposure of the 
antigenic determinant of FAC2 on CPa-1. 
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